802 related articles for article (PubMed ID: 33033392)
21. Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.
Clough JN; Hill KL; Duff A; Sharma E; Ray S; Mawdsley JE; Anderson S; Irving PM; Samaan MA
Inflamm Bowel Dis; 2020 Sep; 26(10):e125-e126. PubMed ID: 32592475
[No Abstract] [Full Text] [Related]
22. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.
Al-Ani AH; Prentice RE; Rentsch CA; Johnson D; Ardalan Z; Heerasing N; Garg M; Campbell S; Sasadeusz J; Macrae FA; Ng SC; Rubin DT; Christensen B
Aliment Pharmacol Ther; 2020 Jul; 52(1):54-72. PubMed ID: 32348598
[TBL] [Abstract][Full Text] [Related]
23. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Inflammatory Bowel Disease Collaborators
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
[TBL] [Abstract][Full Text] [Related]
24. IBD in the COVID-19 era: the value of international collaboration.
Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
[No Abstract] [Full Text] [Related]
25. Epidemiology of inflammatory bowel disease.
Loftus EV; Sandborn WJ
Gastroenterol Clin North Am; 2002 Mar; 31(1):1-20. PubMed ID: 12122726
[TBL] [Abstract][Full Text] [Related]
26. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040
[TBL] [Abstract][Full Text] [Related]
27. Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak.
Rimondi A; Tontini GE; Mazza S; Caprioli F; Sangiovanni A; Lampertico P; Vecchi M
Inflamm Bowel Dis; 2020 Sep; 26(10):e128-e129. PubMed ID: 32720979
[No Abstract] [Full Text] [Related]
28. Safety of biologics in inflammatory bowel disease patients with COVID-19.
Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
[TBL] [Abstract][Full Text] [Related]
29. Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
Al-Ani AH; Prentice RE; Christensen B
J Crohns Colitis; 2020 Dec; 14(12):1796. PubMed ID: 32929469
[No Abstract] [Full Text] [Related]
30. The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.
Hernández Ramírez V; López Serrano P
Rev Esp Enferm Dig; 2021 Feb; 113(2):153-154. PubMed ID: 33467860
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
Berte' R; Mazza S; Stefanucci MR; Noviello D; Costa S; Ciafardini C; Mileti E; Mapelli M; Pasqualato S; Pinto S; Favale A; Vecchi M; Neurath MF; Atreya R; Fantini MC; Facciotti F; Caprioli F
J Crohns Colitis; 2021 May; 15(5):864-868. PubMed ID: 33211810
[TBL] [Abstract][Full Text] [Related]
32. Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?
Fan D; Gearry RB
Aliment Pharmacol Ther; 2021 Jul; 54(2):208-209. PubMed ID: 34170535
[TBL] [Abstract][Full Text] [Related]
33. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF
Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507
[No Abstract] [Full Text] [Related]
34. Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
Allocca M; Fiorino G; Furfaro F; Gilardi D; Radice S; D'Amico F; Zilli A; Danese S
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1882-1883. PubMed ID: 32304737
[TBL] [Abstract][Full Text] [Related]
35. Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.
Queiroz NSF; Barros LL; Azevedo MFC; Oba J; Sobrado CW; Carlos AS; Milani LR; Sipahi AM; Damião AOMC
Clinics (Sao Paulo); 2020; 75():e1909. PubMed ID: 32321117
[TBL] [Abstract][Full Text] [Related]
36. Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
McGregor CG; Adams A; Sadler R; Arancibia-Cárcamo CV; Palmer R; Ambrose T; Brain O; Walsh A; Klenerman P; Travis SP; Croft NM; Lindsay JO; Satsangi J
Gut; 2021 Dec; 70(12):2398-2400. PubMed ID: 33579788
[No Abstract] [Full Text] [Related]
37. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS
J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973
[TBL] [Abstract][Full Text] [Related]
38. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic.
Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X
J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719
[TBL] [Abstract][Full Text] [Related]
39. Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
Behzad C; Taheri H; Kashifard M
Inflamm Bowel Dis; 2020 Oct; 26(11):e140. PubMed ID: 32901275
[No Abstract] [Full Text] [Related]
40. PREVALENCE AND PREDICTIVE FACTORS ASSOCIATED WITH POSITIVITY OF SARS-COV-2 SEROLOGICAL MARKERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT AN IBD REFERRAL CENTER.
Ferreira SDC; Parra RS; Feitosa MR; Feres O; Santana RC; Troncon LEA
Arq Gastroenterol; 2022; 59(2):170-176. PubMed ID: 35830024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
